Literature DB >> 20420577

MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings.

Emanuela Turillazzi1, Irene Riezzo, Margherita Neri, Stefania Bello, Vittorio Fineschi.   

Abstract

Studies conducted in humans or in animals explored the presence, nature and potential causes of 3,4-methylenedioxymethamphetamine (MDMA) toxicity. According to literature, there are four principal types of such serious toxicity: hepatic, cardiovascular, cerebral and hyperpyrexic. The molecular mechanisms involved in the genesis of these toxic effects are not yet fully clarified, but the oxidative stress, excitotoxicity, and mitochondrial dysfunction appear to be causal events that converge to mediate MDMA-induced toxicity. Studies conducted on animals demonstrated that the acute administration of MDMA elicits cardiovascular responses that are similar to those elicited by d-amphetamine, and that these responses appear to involve catecholaminergic and non-catecholaminergic-dependent mechanisms. Although there is undeniable evidence of MDMA-induced cardiac toxicity, the mechanism responsible remains to be clarified. While many reports both in humans and in animals have demonstrated MDMA-induced liver damage, the underlying mechanism accounting for hepatic toxicity is poorly understood. Various mechanisms may contribute to MDMA-induced liver toxicity, including the metabolism of MDMA, the increased efflux of neurotransmitters, the oxidation of biogenic amines, and hyperthermia. The molecular mechanisms involved in the genesis of these toxic effects are not yet fully clarified, but the oxidative stress, excitotoxicity, and mitochondrial dysfunction appear to be causal events that converge to mediate MDMA-induced neurotoxicity, as measured by loss of various markers of dopaminergic and serotonergic terminals. The evidence is overwhelming that MDMA produces acute and long-lasting toxic anatomic effects in animals and humans. Anatomical and functional MDMA consequences must be better understood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420577     DOI: 10.2174/138920110791591481

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  12 in total

Review 1.  Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

2.  Acceleration of cardiovascular-biological age by amphetamine exposure is a power function of chronological age.

Authors:  Albert Stuart Reece; Amanda Norman; Gary Kenneth Hulse
Journal:  Heart Asia       Date:  2017-01-10

Review 3.  Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.

Authors:  Amber Arain; Geert Robaeys
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Authors:  Jason Grebely; Geert Robaeys; Philip Bruggmann; Alessio Aghemo; Markus Backmund; Julie Bruneau; Jude Byrne; Olav Dalgard; Jordan J Feld; Margaret Hellard; Matthew Hickman; Achim Kautz; Alain Litwin; Andrew R Lloyd; Stefan Mauss; Maria Prins; Tracy Swan; Martin Schaefer; Lynn E Taylor; Gregory J Dore
Journal:  Int J Drug Policy       Date:  2015-07-17

Review 5.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

Review 6.  Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Laura E Halpin; Stuart A Collins; Bryan K Yamamoto
Journal:  Life Sci       Date:  2013-07-24       Impact factor: 5.037

Review 7.  Legal highs: staying on top of the flood of novel psychoactive substances.

Authors:  David Baumeister; Luis M Tojo; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

8.  Cardiac beriberi: morphological findings in two fatal cases.

Authors:  Stefania Bello; Margherita Neri; Irene Riezzo; Mohammad Shafie Othman; Emanuela Turillazzi; Vittorio Fineschi
Journal:  Diagn Pathol       Date:  2011-01-19       Impact factor: 2.644

9.  Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy).

Authors:  Shabnam Movassaghi; Zahra Nadia Sharifi; Farzaneh Mohammadzadeh; Mansooreh Soleimani
Journal:  Iran J Basic Med Sci       Date:  2013-08       Impact factor: 2.699

Review 10.  Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease.

Authors:  Byoung-Joon Song; Mohamed A Abdelmegeed; Lauren E Henderson; Seong-Ho Yoo; Jie Wan; Vishnudutt Purohit; James P Hardwick; Kwan-Hoon Moon
Journal:  Oxid Med Cell Longev       Date:  2013-04-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.